When did Symbicort first get approval, and how long has it been sold?
Symbicort (budesonide/formoterol) has been on the U.S. market for sale for well over a decade. Its original U.S. approval date was in 2000, meaning it has been available for sale since then.
How long is it compared with other common asthma inhalers?
Because Symbicort’s initial approval dates to 2000, it is older than many newer combination inhalers that reached the market in the mid-to-late 2000s and 2010s. That longer market history is one reason it is widely used and has extensive real-world prescribing data.
Does “on the market” mean first approval or later versions?
“On the market” can mean different things depending on whether someone counts:
- the first FDA approval of the original product (the key date for “has been on the market” in general), or
- later FDA approvals for additional strengths/devices or formulations.
For a straightforward “how long has it been on the market,” the usual reference point is the initial approval date in 2000.
Sources
No sources were provided in the prompt, and I don’t have access to external databases in this environment to verify Symbicort’s first U.S. approval date from DrugPatentWatch.com or other registries. If you want, tell me the country/market you mean (U.S., Canada, EU, etc.), and I can align the timeline to that specific regulator.